Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2008-04-02
2010-10-19
Ewoldt, G. R (Department: 1644)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S184100, C536S001110
Reexamination Certificate
active
07815910
ABSTRACT:
A composition comprising an aqueous solution comprising:(i) at least one antigen or at least one in vivo generator of a compound comprising an amino acid sequence, and(ii) as an adjuvant of immunity, a surfactant, or a mixture of surfactants, having an overall HLB number of between 5 and 15.
REFERENCES:
patent: 3678149 (1972-07-01), Prigal
patent: 5424067 (1995-06-01), Brancq et al.
patent: 6103770 (2000-08-01), Trouve
patent: 6117432 (2000-09-01), Ganne
patent: 6274149 (2001-08-01), Ganne
patent: 7422748 (2008-09-01), Aucouturier et al.
Abstract for Griffin, W.C. “Calculation of HLB Values of Non-Ionic Surfactants”,Journal of the Society of Cosmetic Chemists 5, 259. (1954).
Brancq et al., Abstract of FR 2649012 “Injectable Multi-Phase Emulsions”,esp@cenetDatabase Worldwide (Jan. 1991).
Ganne et al., Abstract of FR 2755715, “Adjuvant, Notamment Sous Forme D'Une Emulsion Contenant Un Cation Metallique Trivalent Et Composition Vaccinale Le Comprenant (A1 B1) Adjuvant, Notamment Sous Forme D'Une Emulsion Contenant Un Cation Metallique Trivalent Et Composition Vaccinale Le Comprenant”esp@cenetDatabase Worldwide (Apr. 1998).
Ganne, Abstract of FR 2733151 “Therapeutic Composition Comprising an Antigen or an in Vivo Generator of a Compound Comprising an Amino Acid Sequence”,esp@cenetDatabase Worldwide (Oct. 1996).
Garrett, P. R., “Defoaming: Theory and Industrial Applications,Surfactant Science Series”; vol. 45, p. 300, Marcel Dekker Inc., New York, New York (1993).
O'Neil et al., J Pharm Science vol. 61 (6): 863, (1972).
Perlaza, et al., Infec. & Immun., vol. 66, No. 6, pp. 3423-3428, (1972).
Trouve, Abstract of FR 2729307 “Utilization of Ethoxylated Fatty Acid Esters as Self-Emulsifiable Compounds”,esp@cenetDatabase Worldwide (Jul. 1996).
Unknown, The Thesaurus of Chemical Products, vol. II: Tradename to Generic, pp. 64, and 283-284, Chemical Publishing Company, New York, New York (1986).
Aucouturier Jerome
Ganne Vincent
Trouve Gerard
Ewoldt G. R
Hunton & Williams LLP
Societe d'Exploitation de Produits pour les Industries Chimiques
LandOfFree
Vaccine composition and use of surfactants as adjuvants of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine composition and use of surfactants as adjuvants of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine composition and use of surfactants as adjuvants of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4196320